Researchers reported a novel bacterial immune system that produces tailless, non-infectious phages.
iStock, koto_feja
Microbiologists have studied bacterial safety mechanisms in the direction of phages for a few years. Nonetheless until decrease than a decade prior to now, there have been only a few acknowledged bacterial immune strategies: induced suicide mechanisms, restriction-modification, and CRISPR-Cas strategies.1-3
In 2018, microbiologist Rotem Sorek and his colleagues on the Weizmann Institute revealed that bacterial antiphage safety mechanisms are far more quite a few than initially thought.4 Since then, Sorek’s crew and others have discovered various novel bacterial immune strategies, along with the Bil system (a principal ingredient of the system is the Bil protein).5 Sorek subsequent wanted to understand how the Bil system works.

Unfavorable staining transmission electron microscope image of tailless phages from lysates of Bil-expressing micro organism.
Jens Hör
In a present analysis in Nature, Sorek and his colleagues confirmed that micro organism can use this technique to covalently join the bacterial protein Bil to the spike protein of an infecting phage’s tail, which is crucial for the tail assembly of its progenies and the an an infection of current host cells.6 The researchers well-known that the presence of Bil in phage-infected micro organism resulted inside the manufacturing of phage progenies that had been each tailless or completely assembled nevertheless a lot much less infectious, defending the rest of the bacterial inhabitants.
The Bil system is mechanistically very similar to ubiquitin pathways on account of it entails the covalent attachment of ubiquitin-like proteins (Ubl) by ubiquitin-conjugating enzymes.7 Sorek’s curiosity inside the Bil protein first piqued resulting from its structural similarity to interferon-stimulated gene 15 (ISG15), a human Ubl, which is the way in which it obtained its title (bacterial ISG15-like, or Bil for transient).8 In individuals, ISG15 is part of an innate antiviral safety pathway that’s acknowledged to protect in the direction of HIV and influenza, although its mechanism should not be well-understood.
“Lots of these bacterial strategies have been confirmed to be the evolutionary origin of varied human immune strategies,” acknowledged microbiologist Jens Hör, a former postdoctoral fellow in Sorek’s lab and coauthor of the analysis. “We thought that if we work out the way in which it really works in micro organism, we’d moreover advance the human space a bit.”

Jens Hör is a microbiologist on the Helmholtz Institute. Hör was a postdoctoral fellow in Rotem Sorek’s laboratory on the Weizmann Institute and coauthor of the analysis.
Jens Hör
Kevin Corbett, a structural biologist on the School of California, San Diego who was not involved inside the analysis, acknowledged that Bil seems to truly resemble the eukaryotic ubiquitination gear. Corbett and his group concurrently revealed a paper on the structural and molecular particulars of the Bil system within the similar downside of Nature.9
“That’s the main time that micro organism have been confirmed to hold out protein conjugation using gear like this, notably a ubiquitin-like protein,” acknowledged Corbett.

Kevin Corbett, structural biologist on the School of California, San Diego. Corbett’s group concurrently revealed a paper that centered on the structural and molecular particulars of Bil in Nature.
Kevin Corbett
To know how Bil works, Sorek’s crew in distinction phage progeny from contaminated micro organism with and with out the system. They carried out density gradient centrifugation to separate phages from bacterial lysates and situated that the micro organism that expressed Bil produced a greater density band inside the gradient. When the scientists isolated the higher density band and thought of it under a transmission electron microscope, they’d been surprised by the sight of tailless phages. The crew believes that the higher buoyant density might very nicely be outlined by the higher DNA-to-protein ratio in tailless phages.
Whereas not all the phage progenies end up tailless, Sorek and his crew confirmed that even the completely assembled progenies confirmed a diminished performance of infecting totally different cells. By performing immunoprecipitation mass spectrometry, the authors confirmed that Bil is especially conjugated to the spike protein on the tip of the phage’s tail. Hör acknowledged that Bil’s conjugation to the spike protein in all probability inhibits the interaction between the phage and its entry receptor on new host cells, which can make clear why plenty of the tailed progenies are unable to infect.
Hör talked about that some phages have enzymatic domains of their tails which may reverse Ubl conjugation reactions similar to the one carried out by Bil. “One very important question that we didn’t reply in our analysis is how phages can overcome bacterial safety by the Bil system,” he acknowledged.
- Lopatina A, et al. Abortive an an infection: Bacterial suicide as an antiviral immune method. Annu Rev Virol. 2020;7(1):371-384.
- Heitman J. On the origins, constructions and options of restriction-modification enzymes. Genet Eng (N Y). 1993;15:57-108.
- Hille F, Charpentier E. CRISPR-Cas: Biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci. 2016;371(1707):20150496.
- Doron S, et al. Systematic discovery of antiphage safety strategies inside the microbial pangenome. Science. 2018;359(6379):eaar4120.
- Millman A, et al. An expanded arsenal of immune strategies that defend micro organism from phages. Cell Host Microbe. 2022;30(11):1556-1569.e5.
- Hör J, et al. Micro organism conjugate ubiquitin-like proteins to intrude with phage assembly. Nature. 2024;631(8022):850-856.
- Cappadocia L, Lima CD. Ubiquitin-like protein conjugation: Constructions, chemistry, and mechanism. Chem Rev. 2018;118(3):889-918.
- Perng YC, Lenschow DJ. ISG15 in antiviral immunity and previous. Nat Rev Microbiol. 2018;16(7):423-439.
- Chambers LR, et al. A eukaryotic-like ubiquitination system in bacterial antiviral defence. Nature. 2024;631(8022):843-849.